New acne gel could offer gentler alternative to standard treatment
NCT ID NCT07473895
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new topical gel containing 5% spironolactone against a standard 0.1% adapalene gel for treating acne. Forty people with mild to moderate acne will apply each gel to opposite sides of their face, allowing direct comparison. The goal is to see if the spironolactone gel reduces acne lesions with fewer side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut University
Asyut, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentle cream outperform harsh acne drugs?
- Can acne drug harm the eyes? new study investigates
- A new serum aims to clear acne and boost skin confidence
- Head-to-Head: which acne cream works better for clear skin?
- Acne Treatment's Oil-Reducing power put to the test
- AI writes acne guide, students score same as human version